Does Metformin Reduce the Risk of Long COVID? What the Evidence Shows

Emerging research suggests metformin, a widely used diabetes drug, may reduce the risk of long COVID when started early during infection. Here’s what the science shows.
Wellness Info
Wellness Info

Emerging research suggests metformin, a widely used diabetes drug, may reduce the risk of long COVID when started early during infection. Here’s what the science shows.

Learn safe, evidence-backed home remedies for mild diarrhea. From rice water and probiotics to bananas and ginger, understand what works, what doesn’t, and how to support gut recovery naturally.

Inaccurate typhoid tests like Widal and Typhi Dot are fueling antibiotic misuse and antimicrobial resistance. Learn why reliable diagnostics are key to fighting AMR.

Measles cases are rising worldwide after COVID-19 disrupted vaccination programs. Discover why this preventable disease is resurging and how timely MMR vaccination can stop future outbreaks.

In initial phase, four medications are used for up to 2 months i.e., Isoniazid, rifampicin, pyrazinamide and ethambutol. The purpose of concurrent use of 4 drugs during the initial phase is to reduce bacterial population as soon as possible and to prevent drug resistant bacteria.

Tuberculosis (TB) is still one of the world’s top infectious diseases. Discover what TB is, how it spreads, and why early diagnosis and treatment are vital.

Private clinics are vital for healthcare access in Pakistan but are increasingly linked to antibiotic resistance. Learn how unregulated practices and lack of pharmacists contribute to this growing crisis and what can be done to stop it.

Can costly auto-disable syringes really stop HIV and Hepatitis in Pakistan? Explore hidden risks and real evidence.